Effect of renal impairment on the pharmacokinetics of prucalopride: a single- dose open-label Phase I study

• Egile Nagusiak: Smith WB (Egilea), Mannaert E (Egilea), Verhaeghe T (Egilea), Kerstens R (Egilea), Vandeplassche L (Egilea), Van de Velde V (Egilea)
• Formatua: Liburua
• Argitaratua: Dove Medical Press, 2012-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

William B Smith,1 Erik Mannaert,2 Tom Verhaeghe,2 René Kerstens,3 Lieve Vandeplassche,3 Vera Van de Velde41Volunteer Research Group and New Orleans Center for Clinical Research, The University of Tennessee Medical Center, Knoxville, TN, USA; 2Janssen Research and Development, a division o...